Pharmacogenetics

Research Frontiers in Pharmacogenetics of Tyrosine Kinase Inhibitor Resistance

Analysis of acquired mutations in BCR-ABL and EGFR kinase domains conferring resistance to imatinib and erlotinib therapy.

All Pharmacogenetics PhD categories